34243-96-4 Usage
Uses
Used in Pharmaceutical Industry:
Fenbufen is used as an analgesic and anti-inflammatory agent for the treatment of conditions such as arthritis. It is effective in managing the symptoms associated with inflammatory diseases due to its action on the biochemical pathways that cause pain and swelling.
Used in Pain Management:
Fenbufen serves as a pain reliever, particularly for those suffering from chronic conditions that involve inflammation. Its ability to inhibit the production of pro-inflammatory chemicals makes it a valuable option for patients in need of pain relief.
Used in Topical Treatments:
In the form of topical creams, fenbufen is used for localized treatment of inflammation and pain. This application allows for targeted relief, minimizing systemic side effects and providing direct action at the site of inflammation.
Cautionary Note:
While fenbufen is generally well-tolerated, it is important to consider the potential gastrointestinal and cardiovascular side effects associated with NSAIDs. It should be used with caution in populations such as the elderly and those with a history of stomach ulcers or heart disease, due to the increased risk of adverse reactions.
Check Digit Verification of cas no
The CAS Registry Mumber 34243-96-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,4,2,4 and 3 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 34243-96:
(7*3)+(6*4)+(5*2)+(4*4)+(3*3)+(2*9)+(1*6)=104
104 % 10 = 4
So 34243-96-4 is a valid CAS Registry Number.
34243-96-4Relevant academic research and scientific papers
4-phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibiting activity
-
, (2008/06/13)
4-phenyl-4-oxo-butanoic acid derivatives for use in the treatment of the human or animal body by therepy; particularly as kynurenine-3-hydroxylase inhibitors, in the prevention and/or treatment of a neurodegenerative disease wherein the inhibition of such an enyzme is needed. The present invention further comprises a selected class of the above mentioned 4-phenyl-4-oxo-butanoic acid derivatives, their pharmaceutically acceptable salts, a process for their preparation and pharmaceutical compositions containing them.
Spiro-3-hetero-azolones for treatment of diabetic complications
-
, (2008/06/13)
Spiro-oxazolidones, -thiazolidones and -imidazolidones are disclosed which are useful as aldose reductase inhibitors and as therapeutic agents for the treatment of complications arising from diabetes. Pharmaceutical compositions containing the spiro compo
SUBSTITUTED THIO-SUBSTITUTED BENZYL-PROPIONYL-L-PROLINES
-
, (2008/06/13)
This disclosure describes novel substituted ω-aroyl(propionyl or butyryl)-L-prolines and the esters and cationic salts thereof which are useful as hypotensive agents in mammals.
